Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.

Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.
复制标题

DOI:
10.1016/j.cell.2015.01.001
复制
发表时间:
2015-01-29
期刊:
影响因子:
64.5
通讯作者:
Newton AC
Newton AC
中科院分区:
生物学1区
文献类型:
--
作者:
Antal CE;Hudson AM;Kang E;Zanca C;Wirth C;Stephenson NL;Trotter EW;Gallegos LL;Miller CJ;Furnari FB;Hunter T;Brognard J;Newton AC

文献摘要

参考文献

被引文献

相似文献

蛋白激酶C(PKC)同工酶仍然难以捉摸的癌症目标,尽管明确的肿瘤促进功能的有效配体,佛波酯,和他们的突变的患病率。我们分析了在人类癌症中发现的8%的PKC突变,令人惊讶的是,大多数是功能丧失,没有激活。失功能突变发生在所有的PKC亚组,并阻碍第二信使结合,磷酸化,或催化。通过CRISPR介导的基因组编辑在患者来源的结肠癌细胞系中校正功能丧失的PKCβ突变抑制了异种移植模型中的锚定非依赖性生长并减少了肿瘤生长。半合子缺失促进了锚定非依赖性生长,表明PKCβ单倍不足抑制肿瘤。几个突变是显性负性的,抑制了整体PKC信号输出,生物信息学分析表明,PKC突变与癌症驱动因素中的共现突变合作。这些数据表明,PKC同工酶通常作为肿瘤抑制因子发挥作用,这表明治疗应侧重于恢复而不是抑制PKC活性。
Protein kinase C (PKC) isozymes have remained elusive cancer targets despite the unambiguous tumor promoting function of their potent ligands, phorbol esters, and the prevalence of their mutations. We analyzed 8% of PKC mutations identified in human cancers and found that, surprisingly, most were loss of function and none were activating. Loss-of-function mutations occurred in all PKC subgroups and impeded second-messenger binding, phosphorylation, or catalysis. Correction of a loss-of-function PKCβ mutation by CRISPR-mediated genome editing in a patient-derived colon cancer cell line suppressed anchorage-independent growth and reduced tumor growth in a xenograft model. Hemizygous deletion promoted anchorage-independent growth, revealing that PKCβ is haploinsufficient for tumor suppression. Several mutations were dominant negative, suppressing global PKC signaling output, and bioinformatic analysis suggested that PKC mutations cooperate with co-occurring mutations in cancer drivers. These data establish that PKC isozymes generally function as tumor suppressors, indicating that therapies should focus on restoring, not inhibiting, PKC activity.
DOI: 10.1126/scisignal.2004088
发表时间: 2013-04-02
期刊: Science signaling
影响因子: 7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者: Schultz N
DOI: 10.1074/jbc.m306979200
发表时间: 2004-03-12
影响因子: 4.8
作者:
Abbas, T;White, D;Bargonetti, J
通讯作者: Bargonetti, J
DOI: 10.1016/j.chembiol.2014.02.008
发表时间: 2014-04-24
影响因子: --
作者:
Antal, Corina E.;Violin, Jonathan D.;Newton, Alexandra C.
通讯作者: Newton, Alexandra C.
DOI: 10.1042/bj3330631
发表时间: 1998-08-01
影响因子: 4.1
作者:
Garcia-Paramio, P;Cabrerizo, Y;Parker, PJ
通讯作者: Parker, PJ
DOI: 10.1038/sj.onc.1209065
发表时间: 2006-01-01
期刊: ONCOGENE
影响因子: 8
作者:
D'Costa, AM;Robinson, JK;Denning, MF
通讯作者: Denning, MF